The association studies of ADIPOQ with type 2 diabetes mellitus in Chinese populations

Diabetes/Metabolism Research and Reviews

Volumn 28, Issue 7, 2012, Pages 551-559

  Li, Yiping ^a   Yang, Ying ^a   Shi, Li ^b   Li, Xianli ^a   Zhang, Ying ^a   Yao, Yufeng ^b  

^a The Second People's Hospital of Yunnan Province   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

ADIPOQ; Chinese populations; Diabetes mellitus, type 2; Single nucleotide polymorphisms

Indexed keywords

ADIPONECTIN;

ADIPOQ GENE; CHINA; CHINESE; ETHNICITY; GENE; GENETIC ASSOCIATION; GEOGRAPHIC DISTRIBUTION; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPONECTIN; CHINA; DIABETES MELLITUS, TYPE 2; GENETIC ASSOCIATION STUDIES; HUMANS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84867086445     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2309     Document Type: Review

References (111)

1. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010; 362(12): 1090-1101.
2. Shapiro L, Scherer PE. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr Biol 1998; 8(6): 335-338.
3. Abbasi F, Chu JW, Lamendola C, et al. Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes 2004; 53(3): 585-590.
4. Tschritter O, Fritsche A, Thamer C, et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2003; 52(2): 239-243.
5. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86(5): 1930-1935.
6. Retnakaran R, Hanley AJ, Raif N, et al. Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications. Diabetologia 2005; 48(5): 993-1001.
7. Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2009; 302(2): 179-188.
8. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257(1): 79-83.
9. Yang WS, Lee WJ, Funahashi T, et al. Plasma adiponectin levels in overweight and obese Asians. Obes Res 2002; 10(11): 1104-1110.
10. Matsubara M, Maruoka S. Katayose S Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 2002; 87(6): 2764-2769.
11. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20(6): 1595-1599.
12. Kumada M, Kihara S, Sumitsuji S, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003; 23(1): 85-89.
13. Mente A, Razak F, Blankenberg S, et al. Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care 2010; 33(7): 1629-1634.
14. Schutte AE, Huisman HW, Schutte R, et al. Differences and similarities regarding adiponectin investigated in African and Caucasian women. Eur J Endocrinol 2007; 157(2): 181-188.
15. Takahashi M, Arita Y, Yamagata K, et al. Genomic structure and mutations in adipose-specific gene, adiponectin. Int J Obes Relat Metab Disord 2000; 24(7): 861-868.
16. Kissebah AH, Sonnenberg GE, Myklebust J, et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci U S A 2000; 97(26): 14478-14483.
17. Mori Y, Otabe S, Dina C, et al. Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p. Diabetes 2002; 51(4): 1247-1255.
18. Vionnet N, Hani EH, Dupont S, et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 2000; 67(6): 1470-1480.
19. Hara K, Boutin P, Mori Y, et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002; 51(2): 536-540.
20. Fumeron F, Aubert R, Siddiq A, et al. Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study. Diabetes 2004; 53(4): 1150-1157.
21. Gibson F, Froguel P. Genetics of the APM1 locus and its contribution to type 2 diabetes susceptibility in French Caucasians. Diabetes 2004; 53(11): 2977-2983.
22. Gu HF, Abulaiti A, Ostenson CG, et al. Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish caucasians. Diabetes 2004; 53(Suppl 1): S31-S35.
23. Populaire C, Mori Y, Dina C, et al. Does the -11377 promoter variant of APM1 gene contribute to the genetic risk for Type 2 diabetes mellitus in Japanese families? Diabetologia 2003; 46(3): 443-445.
24. Vasseur F, Helbecque N, Dina C, et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 2002; 11(21): 2607-2614.
25. Vasseur F, Helbecque N, Lobbens S, et al. Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity. Diabetologia 2005; 48(5): 892-899.
26. Schwarz PE, Towers GW, Fischer S, et al. Hypoadiponectinemia is associated with progression toward type 2 diabetes and genetic variation in the ADIPOQ gene promoter. Diabetes Care 2006; 29(7): 1645-1650.
27. Siitonen N, Pulkkinen L, Lindstrom J, et al. Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study. BMC Med Genet 2011; 12: 5.
28. Xia H, Mo YZ, Bian RW, Shen J, Ma LJ. Correlation between single nucleotide polymorphism of adiponectin gene and type 2 diabetes in Chinese. Chin J Endocrinol Metab 2004; 20(3): 236-237.
29. Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 2002; 3(4): 285-298.
30. Chu MF, Guo LX, Pan Q, Guo FJ, Sun MX, et al. Association of adiponectin gene polymorphism with type 2 diabetes mellitus and carotid artery intima-media thickness. Chin J Endocrinol Metab 2006; 22(1): 24-26.
31. Zhai B, Ye L, Liu JW, Liu J. Interaction of adiponectin and peroxisome proliferator activated receptor gamma 2 gene polymorphisms and their relationship with type 2 diabetes in population from Beijing communities. Chin J Clin Rehabil 2006; 10(4): 28-31.
32. Liu DM, Jin LZ, Yu DM, Li G, Zhang J. Association of adiponectin gene polymorphism with type 2 diabetes. Chin J Diabetes 2004; 12(6): 397-398.
33. Xin YP, Zhang SH, Li QJ, et al. Association between adiponectin SNP45 and type 2 diabetes with cerebral infarction. Chin J Pract Ner Dis 2009; 12(22): 29-30.
34. Wang YX, Zhao L, Yu SG, Liu CM. Correlation of adiponectin gene polymorphism and type 2 diabetes mellitus. Shandong Med J 2010; 50(37): 1-2.
35. Cheng W, Yi HZ, Ma XW. Single nucleotide polymorphism of adiponectin gene 45 site in patients with type 2 diabetes in the south of Henan province. J Zhengzhou Univ (Med Sci) 2007; 42(6): 1145-1147.
36. Wei YL, Hou ZH, Zhao W. The relationship of the adiponectin +45 nucleotide T/G polymorphism with insulin resistance, obesity and type 2 diabetes. Chin J Diabetes 2007; 15(10): 583-585.
37. Li LL, Kang XL, Ran XJ, et al. Associations between 45T/G polymorphism of the adiponectin gene and plasma adiponectin levels with type 2 diabetes. Clin Exp Pharmacol Physiol 2007; 34(12): 1287-1290.
38. Wang SC, Wang ZJ, Wang ZX. Relationship between gene polymorphism of adiponectin and insulin resistance in different glucose tolerance people. Clin Focus 2007; 22(5): 318-321.
39. Bu RF, Wu WJ, Deng ZX, Xu L, Gu MF, et al. Relationship between adiponectin gene polymorphism, serum adiponectin level and type 2 diabetes. J Med Postgrad 2007; 20(3): 285-289.
40. Gu MF, Wu WJ, Bu RF, et al. Studies on serum adiponectin level and SNP45 of adiponectin gene in patients with type 2 diabetes. J Jiangsu Univ (Med Ed) 2007; 17(6): 498-502.
41. Wang CJ, Wang YM, Ru Y, et al. Association of SNP45 in adiponectin gene with obesity and insulin resistance. Chin J Diabetes 2005; 13(5): 324-325.
42. Wang Y, Zhang J, Huang QY. Association studies of the APM1 SNP T45G with type 2 diabetes in Han population of Hubei Province. Yi Chuan 2008; 30(6): 711-715.
43. Chen QY, Su QJ, Qin WW, et al. Association of the T-G polymorphism in adiponectin(exon2) with diabetes in Zhuang people in Guanxi. J Guangxi Med Univ 2008; 25(6): 821-824.
44. Wang Y, He L, Huang CL. Correlation of adiponectin gene polymorphism and type 2 diabetes mellitus in Han population of Guangdong. J Trop Med 2007; 7(7): 651-653.
45. Tso AW, Sham PC, Wat NM, et al. Polymorphisms of the gene encoding adiponectin and glycaemic outcome of Chinese subjects with impaired glucose tolerance: a 5-year follow-up study. Diabetologia 2006; 49(8): 1806-1815.
46. Yang HY, Zhao YJ, Xu YS, Li H, Liu H. The association study of adiponectin gene SNP+45(T/G) with type 2 diabetes in Kunming Han population. J Pract Med 2011; 27(1): 44-46.
47. Kang Z, Sun CK, Zhao HZ, et al. Correlation between polymorphism of adiponectin gene and type 2 diabetes mellitus in Bai and Han population at Dali area. Chin J Diabetes 2008; 16(12): 718-720.
48. Wang Y, Zhang D, Liu Y, et al. Association study of the single nucleotide polymorphisms in adiponectin-associated genes with type 2 diabetes in Han Chinese. J Genet Genomics 2009; 36(7): 417-423.
49. Shi XH, Jin F, Sun L, et al. Association of the polymorphism of SNP+45(T/G) in adiponectin gene with type 2 diabetes. J Clin Rehabil Tissue Eng Res 2007; 11(25): 4941-4944.
50. Dong Y, Li G, Lou TH, et al. Relationship between adiponectin gene polymorphisms and type 2 diabetes. Acad J Shanghai Second Med Univ 2004; 24(12): 1001-1003, 1020.
51. Ye H, Zhuang J. Association of the polymorphism of SNP+45(T/G) in adiponectin gene with type 2 diabetes in Chinese Han population. Pharmaceut Care Res 2009; 9(2): 158-160.
52. Sun H, Gong ZC, Yin JY, et al. The association of adiponectin allele 45T/G and -11377C/G polymorphisms with type 2 diabetes and rosiglitazone response in Chinese patients. Br J Clin Pharmacol 2008; 65(6): 917-926.
53. Hao JM, Diao ZH, Liu JX. Correlation between single nucleotide polymorphism of adiponectin gene and type 2 diabetes in Han population of Hainan. Hainan Med J 2009; 20(7): 1-3, 41.
54. Li YP, Zhang Y, Song DP, et al. Single nucleotide polymorpism haplotypes of adiponectin gene are associated with type 2 diabetes in Han population. Chin J Diabetes 2011; 19(2): 101-104.
55. Duan WR, Zhao T, Ding YM, Li XH. Association of adiponectin gene polymorphism and serum adiponectin level with diabetic retinopathy. Chin J Diabetes 2008; 16(12): 715-717, 720.
56. Wang SF, Zhao JJ, Jiang Q, Gao L, Ma H. The correlation between adiponectin gene polymorphism and type 2 diabetes. Chin J Endocrinol Metab 2007; 23(1): 51-52.
57. Yang WS, Yang YC, Chen CL, et al. Adiponectin SNP276 is associated with obesity, the metabolic syndrome, and diabetes in the elderly. Am J Clin Nutr 2007; 86(2): 509-513.
58. Zhang J, Wang Y, Yuan HL, et al. Correlation between single nucleotide polymorphism of adiponectin and type 2 diabetes in Xinjiang Uygur population. J Nongken Med 2006; 28(6): 401-406.
59. Zhang HX, Li YY, Zou CY, et al. Relationship between polymorphism of adiponectin gene and type 2 diabetes with vascular dieases. Shandong Med J 2007; 47(10): 1-2.
60. Wang K, Nie XL, Liu DM, Yu DM. The association of adiponcetin gene polymorphism with insulin resistance and type 2 diabetes mellitus. J Tianjin Med Univ 2009; 15(2): 190-193, 212.
61. Ru Y, Ma M, Ma T, et al. Association of SNP276 in adiponectin gene with type 2 diabetes mellitus and insulin sensitivity. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2005; 22(6): 698-701.
62. Laumen H, Saningong AD, Heid IM, et al. Functional characterization of promoter variants of the adiponectin gene complemented by epidemiological data. Diabetes 2009; 58(4): 984-991.
63. Sheng TX, Li ZN, Pian LN, et al. Association between the adiponectin gene and type 2 diabetes in Yanbian Han and Korean Chinese Populations. Int J Genet 2009; 32(6): 395-399.
64. Yang M, Qiu CC, Chen W, et al. Identification of a regulatory single nucleotide polymorphism in the adiponectin (APM1) gene associated with type 2 diabetes in Han nationality. Biomed Environ Sci 2008; 21(6): 454-459.
65. Wang X, Zhang S, Chen Y, et al. APM1 gene variants -11377C/G and 4545G/C are associated respectively with obesity and with non-obesity in Chinese type 2 diabetes. Diabetes Res Clin Pract 2009; 84(3): 205-210.
66. Ye F, He L, Li JN, Dong CP, Yu J. Association of SNPs in the proximal promoter region of the APM1 gene with obesity and type 2 diabetes. J Xi'an Jiaotong Univ (Med Sci) 2008; 29(1): 74-76, 83.
67. Shi XH, Jin F, Wang L, Yang Z. Association of SNPs-11377C/G in proximal promoter region of adiponectin gene with type 2 diabetes in Northern Chinese Han population. J Clin Rehabil Tissue Eng Res 2007; 11(34): 6815-6818.
68. Waki H, Yamauchi T, Kamon J, et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 2003; 278(41): 40352-40363.
69. Lu XW, Lai B. On the association of adiponectin gene rs6773957(A/G) polymorphism with type 2 diabetes mellitus. Acta Acad Med Xuzhou 2007; 27(1): 22-25.
70. Ling H, Waterworth DM, Stirnadel HA, et al. Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study. Obesity (Silver Spring) 2009; 17(4): 737-744.
71. Ru Y, Wang CJ, Wang YM, et al. Association of adiponectin gene variants with type 2 diabetes. Chin J Endocrinol Metab 2005; 21(4): 322-323.
72. Kondo H, Shimomura I, Matsukawa Y, et al. Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. Diabetes 2002; 51(7): 2325-2328.
73. Ru Y, Wang CJ, Wang YM, Zhang Q, Hu HL. Association of R221S mutation in adiponectin gene with type 2 diabetes. Chin J Diabetes 2004; 12(6): 390-392.
74. Sun LP, Wang WJ, Yang KJ, et al. Association of R221S and H241P polymorphism in adiponectin gene with type 2 diabetes. Mod Prev Med 2010; 37(12): 2315-2317.
75. Lan CL, Zhang SZ, Liu HK, et al. Association of +712A/G and +349A/G polymorphisms in the adiponectin gene with type 2 diabetes mellitus in Han population. Chin J Gerontol 2009; 29(6): 700-703.
76. Menzaghi C, Ercolino T, Di Paola R, et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002; 51(7): 2306-2312.
77. Liu H, Chen S, Zhang S, et al. Adiponectin gene variation -4522C/T is associated with type 2 diabetic obesity and insulin resistance in Chinese. J Genet Genomics 2007; 34(10): 877-884.
78. Xu MT, Chen XC, Jin LZ, Chen WQ. A Meta-analysis on the association between adiponectin gene 45T/G/276G/T polymorphisms and type 2 diabetes in Chinese population. Zhonghua Liu Xing Bing Xue Za Zhi 2008; 29(11): 1132-1136.
79. Li Y, Li X, Shi L, et al. Association of adiponectin SNP+45 and SNP+276 with type 2 diabetes in Han Chinese populations: a meta-analysis of 26 case-control studies. PLoS One 2011; 6(5): e19686.
80. Li SB, Yang GY, Li L, et al. Meta-analysis on the association of apM1 gene single nucleotide polymorphisms and type 2 diabetes mellitus in Chinese population. Chin J Endocrinol Metabol 2008; 24(5): 496-500.
81. Menzaghi C, Trischitta V, Doria A. Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes 2007; 56(5): 1198-1209.
82. Han LY, Wu QH, Jiao ML, et al. Associations between single-nucleotide polymorphisms (+45T>G, +276G>T, -11377C>G, -11391G>A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetologia 2011; 54(9): 2303-2314.
83. Li S, Li L, Li K, et al. Association of adipose most abundant transcript 1 gene (apM1) with type 2 diabetes mellitus in a Chinese population: a meta-analysis of case-control studies. Clin Endocrinol (Oxf) 2008; 68(6): 885-889.
84. Gong M, Long J, Liu Q, Deng HC. Association of the ADIPOQ rs17360539 and rs266729 polymorphisms with type 2 diabetes: a meta-analysis. Mol Cell Endocrinol 2010; 325(1-2): 78-83.
85. Schwarz PE, Towers GW, van der Merwe A, et al. Global meta-analysis of the C-11377G alteration in the ADIPOQ gene indicates the presence of population-specific effects: challenge for global health initiatives. Pharmacogenomics J 2009; 9(1): 42-48.
86. Comuzzie AG, Funahashi T, Sonnenberg G, et al. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab 2001; 86(9): 4321-4325.
87. He L, Liu P, Ye F, Li JN, Dong CP. Association of SNPs in proximal promoter region of APM1 gene with serum adiponectin level and type 2 diabetes in Shaanxi Chinese. J Fourth Mil Med Univ 2006; 27(16): 1493-1495.
88. Cai QY, Shi YX, Li YJ, Tao G. Association of gene polymorphism in promoter region of adiponectin gene and carotid artery intima-media thickness in patients with type 2 diabetes melllitus of Fujian. Chin J Endocrinol Metabol 2009; 25(2): 136-138.
89. Du PF, Xu M, Hong J, et al. Adiponectin gene polymorphism and its association with insulin resistance. Chin J Diabetes 2004; 12(6): 393-396.
90. Indulekha K, Anjana RM, Surendar J, Mohan V. Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113). Clin Biochem 2011; 44(4): 281-287.
91. Li YP, Yao YF, Zhang Y, et al. Correlation between adiponectin gene polymorphisms and type 2 diabetes. Chin J Mod Med 2010; 20(7): 961-965, 970.
92. Verges B. New insight into the pathophysiology of lipid abnormalities in type 2 diabetes. Diabetes Metab 2005; 31(5): 429-439.
93. Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 2001; 108(12): 1875-1881.
94. Fruebis J, Tsao TS, Javorschi S, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 2001; 98(4): 2005-2010.
95. Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002; 8(11): 1288-1295.
96. Schulze MB, Rimm EB, Shai I, Rifai N, Hu FB. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Diabetes Care 2004; 27(7): 1680-1687.
97. Wu WJ, Bu RF, Liu GP, et al. Study on serum adiponectin level and SNP45 in adiponectin gene in type 2 diabetes patients with hypertriglyceridemia. Chin J Diabetes 2008; 16(7): 402-404.
98. Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999; 100(25): 2473-2476.
99. Ouchi N, Kihara S, Arita Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001; 103(8): 1057-1063.
100. Looker HC, Krakoff J, Funahashi T, et al. Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes. J Clin Endocrinol Metab 2004; 89(8): 4010-4017.
101. Lin JY, Shi YX, Li YJ, Tao G. Association of gene polymorphism in promoter region of adiponectin gene and albuminuria in patients with type 2 diabetes mellitus. Chin J Diabetes Mellitus 2010; 2(2): 106-110.
102. Iwaki M, Matsuda M, Maeda N, et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003; 52(7): 1655-1663.
103. Yu JG, Javorschi S, Hevener AL, et al. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 2002; 51(10): 2968-2974.
104. Combs TP, Wagner JA, Berger J, et al. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology 2002; 143(3): 998-1007.
105. Li Z, Peng X, Wu Y, et al. The influence of adiponectin gene polymorphism on the pioglitazone response in the Chinese with type 2 diabetes. Diabetes Obes Metab 2008; 10(9): 794-802.
106. Xu S, Yin X, Li S, et al. Genomic dissection of population substructure of Han Chinese and its implication in association studies. Am J Hum Genet 2009; 85(6): 762-774.
107. Heidemann C, Kroll L, Icks A, Lampert T, Scheidt-Nave C. Prevalence of known diabetes in German adults aged 25-69years: results from national health surveys over 15 years. Diabet Med 2009; 26(6): 655-658.
108. Lindahl B, Stenlund H, Norberg M. Increasing glucose concentrations and prevalence of diabetes mellitus in northern Sweden, 1990-2007. Glob Health Action 2010; 3. DOI: 10.3402/gha.v3i0.5222
109. Meisinger C, Strassburger K, Heier M, et al. Prevalence of undiagnosed diabetes and impaired glucose regulation in 35-59-year-old individuals in Southern Germany: the KORA F4 Study. Diabet Med 2010; 27(3): 360-362.
110. Bonaldi C, Vernay M, Roudier C, et al. A first national prevalence estimate of diagnosed and undiagnosed diabetes in France in 18- to 74-year-old individuals: the French Nutrition and Health Survey 2006/2007. Diabet Med 2011; 28(5): 583-589.
111. Estoppey D, Paccaud F, Vollenweider P, Marques-Vidal P. Trends in self-reported prevalence and management of hypertension, hypercholesterolemia and diabetes in Swiss adults, 1997-2007. BMC Public Health 2011; 11: 114.